DNTH vs PLTR · rev $6.2M vs P/E 584, rev $4.48B
Dianthus Therapeutics Inc. (DNTH) versus Palantir Technologies Inc. Class A Common Stock (PLTR) — a side-by-side from cached financials, not a winner call.
Dianthus Therapeutics Inc. (DNTH) is a biotechnology company listed on US.
Palantir Technologies Inc. Class A Common Stock (PLTR) is a software - infrastructure company listed on US. It is led by Alex Karp.
Latest reported DNTH revenue for 2024-12-31 was $6.2M. Net income was -$85.0M. Revenue was up 120.6% from 2023-12-31 to 2024-12-31. DNTH currently screens at market cap $4.40B.
Latest reported PLTR revenue for 2025-12-31 was $4.48B. Net income was $1.63B. Revenue was up 56.2% from 2024-12-31 to 2025-12-31. PLTR currently screens at market cap $317.08B and trailing P/E 584.2.
DNTH currently screens at market cap $4.40B. PLTR currently screens at market cap $317.08B and trailing P/E 584.2.
Not investment advice. Open the DNTH and PLTR stock pages for the full models.
Not investment advice.